Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2015 1
2016 4
2017 1
2018 5
2019 3
2020 5
2021 8
2022 16
2023 9
2024 13
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Examining the Building Blocks of Health Behavior Change in Rheumatology Rehabilitation: A Theory-Driven Qualitative Study.
Berdal G, Kjeken I, Linge AD, Aasvold AM, Tennebø K, Eppeland SG, Hagland AS, Ohldieck-Fredheim G, Valaas HL, Bø I, Klokkeide Å, Azimi M, Dager TN, Sand-Svartrud AL. Berdal G, et al. Among authors: azimi m. J Multidiscip Healthc. 2024 Jul 29;17:3649-3662. doi: 10.2147/JMDH.S472713. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 39100904 Free PMC article.
Effects of a traditional herbal formula containing Melissa officinalis, Pimpinella anisum, and Rosa damascena on anxiety and depression in patients with constipation-predominant irritable bowel syndrome (IBS-C): A double-blind randomized clinical trial.
Azimi M, Shahrbabaki HKD, Raeiszadeh M, Eslami O. Azimi M, et al. Explore (NY). 2024 Nov-Dec;20(6):103013. doi: 10.1016/j.explore.2024.05.011. Epub 2024 May 29. Explore (NY). 2024. PMID: 38937193 Clinical Trial.
Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized, placebo-controlled, phase 1 clinical trial with a six-month follow-up.
Salehi M, Alavi Darazam I, Nematollahi A, Alimohammadi M, Pouya S, Alimohammadi R, Khajavirad N, Porgoo M, Sedghi M, Mahdi Sepahi M, Azimi M, Hosseini H, Mahmoud Hashemi S, Dehghanizadeh S, Khoddami V. Salehi M, et al. Among authors: azimi m. Int Immunopharmacol. 2024 Jun 15;134:112192. doi: 10.1016/j.intimp.2024.112192. Epub 2024 May 17. Int Immunopharmacol. 2024. PMID: 38761778 Clinical Trial.
55 results